Interim PET-directed therapy in limited stage Hodgkin lymphoma initially treated with ABVD

Limited-stage Hodgkin lymphoma (HL) is a highly curable malignancy when treated with combination chemotherapy with or without radiotherapy (RT).[1][1]–[5][2] The majority of patients experience long-term survival but remain at risk for late treatment-related complications, particularly those